DGNM.F Stock Overview
A digital health artificial intelligence company, engages in the development and commercialization of digital therapeutics for people suffering from mental health and neurological disorders. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Diagnamed Holdings Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.013 |
| 52 Week High | CA$0.041 |
| 52 Week Low | CA$0.0058 |
| Beta | -2.09 |
| 11 Month Change | 118.97% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -50.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| DGNM.F | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 0% | -0.3% | 0.4% |
| 1Y | n/a | 13.2% | 32.3% |
Return vs Industry: Insufficient data to determine how DGNM.F performed against the US Healthcare Services industry.
Return vs Market: Insufficient data to determine how DGNM.F performed against the US Market.
Price Volatility
| DGNM.F volatility | |
|---|---|
| DGNM.F Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 10.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: DGNM.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine DGNM.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Fabio Chianelli | www.diagnamed.com |
Diagnamed Holdings Corp., a digital health artificial intelligence company, engages in the development and commercialization of digital therapeutics for people suffering from mental health and neurological disorders. It focuses on CERVAI, a brain health AI platform; and Health GenAI, a suite of generative AI solutions for the healthcare market that includes OpenAI's ChatGPT. The company also develops Dr. GENAI, a personal AI medical chatbot designed to give people to obtain fast and personalized medical information based on a person’s unique medical condition.
Diagnamed Holdings Corp. Fundamentals Summary
| DGNM.F fundamental statistics | |
|---|---|
| Market cap | US$1.71m |
| Earnings (TTM) | -US$433.63k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-3.9x
P/E RatioIs DGNM.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DGNM.F income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$610.02k |
| Earnings | -CA$610.02k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0076 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did DGNM.F perform over the long term?
See historical performance and comparison